Restatement of previously issued condensed interim consolidated financial statements - Balance Sheet (Details) - USD ($)	Jan. 31, 2019	Jul. 31, 2018	Jan. 31, 2018	Jul. 31, 2017	Mar. 27, 2017
Current Assets:
Cash and cash equivalents	$ 2,373,821	$ 1,046,365	$ 2,048,067	$ 2,879,165
Accounts receivable, net	2,296,061	33,555
Inventory, net	1,099,508	12,075
Other current assets	286,439	96,251
Total Current Assets	6,055,829	1,188,246
Property and equipment	645,607	31,536
Notes receivable - noncurrent	1,406,051
Goodwill and Intangible assets	64,921,161	3,187,757
Patents, net	21,987	23,280
Other assets, net	18,821	7,824
TOTAL ASSETS	73,069,456	6,606,854
Current Liabilities:
Accounts payable and accrued expenses	16,863,991	11,044,774
Notes payable, current	40,968,321	320,000
Loans from related parties	13,200	13,864,241
Other current liabilities	4,620
Deferred tax liability	1,929,955
Total Current Liabilities	59,780,087	25,229,015
Notes payable - noncurrent
Other noncurrent liabilities	171,562
Derivative liability - convertible notes	2,353,139
Derivative liability - warrants	192,671
Warrants to be issued		24,962,507
Total Liabilities	62,497,459	50,191,522
Redeemable non-controlling interest	4,073,898
Stockholders' Equity :
Common stock, $.001 par value; authorized 750,000,000 and 750,000,000 shares at January 31, 2019 and July 31, 2018, respectively; 60,362,164 and 22,430,121 issued and outstanding at January 31, 2019 and July 31, 2018, respectively	60,362	22,430
Common stock payable	201,294	2,168,951
Additional paid-in capital	387,380,368	368,388,265
Accumulated deficit	(403,628,069)	(409,386,468)
Accumulated other comprehensive income	800,446	798,422
Non-controlling interest	21,683,698	(5,576,272)
Total Stockholders' Deficiency	10,571,997	(43,584,668)		$ (79,876,231)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	73,069,456	6,606,854
Olaregen Series A Preferred Stock [Member]
Stockholders' Equity :
Convertible Preferred Stock
Series I Convertible Preferred Stock
Stockholders' Equity :
Convertible Preferred Stock		1
Regentys Series A Redeemable Convertible Preferred Stock [Member]
Stockholders' Equity :
Convertible Preferred Stock
Series H Convertible Preferred Stock
Stockholders' Equity :
Convertible Preferred Stock		3			$ 3,000,000
Adjusted [Member]
Current Assets:
Cash and cash equivalents	187,444
Accounts receivable, net	(170,077)
Inventory, net
Other current assets	6,168
Total Current Assets	23,535
Property and equipment
Notes receivable - noncurrent
Goodwill and Intangible assets	(18,713)
Patents, net
Other assets, net
TOTAL ASSETS	4,822
Current Liabilities:
Accounts payable and accrued expenses	(53,104)
Notes payable, current	48,486
Loans from related parties
Other current liabilities	4,620
Deferred tax liability	(540)
Total Current Liabilities	(538)
Notes payable - noncurrent	(149,637)
Other noncurrent liabilities	171,562
Derivative liability - convertible notes	(192,671)
Derivative liability - warrants	192,671
Warrants to be issued
Total Liabilities	21,387
Redeemable non-controlling interest	4,073,898
Stockholders' Equity :
Common stock, $.001 par value; authorized 750,000,000 and 750,000,000 shares at January 31, 2019 and July 31, 2018, respectively; 60,362,164 and 22,430,121 issued and outstanding at January 31, 2019 and July 31, 2018, respectively
Common stock payable
Additional paid-in capital	2,966,116
Accumulated deficit	(167,104)
Accumulated other comprehensive income
Non-controlling interest	(4,073,900)
Total Stockholders' Deficiency	(16,565)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	4,822
Adjusted [Member] | Olaregen Series A Preferred Stock [Member]
Stockholders' Equity :
Convertible Preferred Stock	(1,000,000)
Adjusted [Member] | Series I Convertible Preferred Stock
Stockholders' Equity :
Convertible Preferred Stock
Adjusted [Member] | Regentys Series A Redeemable Convertible Preferred Stock [Member]
Stockholders' Equity :
Convertible Preferred Stock	(1,815,575)
Adjusted [Member] | Series H Convertible Preferred Stock
Stockholders' Equity :
Convertible Preferred Stock
As Previously Reported [Member]
Current Assets:
Cash and cash equivalents	2,186,377	$ 1,046,365
Accounts receivable, net	2,466,138
Inventory, net	1,099,508
Other current assets	280,271
Total Current Assets	6,032,294
Property and equipment	645,607
Notes receivable - noncurrent	1,406,051
Goodwill and Intangible assets	64,939,874
Patents, net	21,987
Other assets, net	18,821
TOTAL ASSETS	73,064,634
Current Liabilities:
Accounts payable and accrued expenses	16,917,095
Notes payable, current	40,919,835
Loans from related parties	13,200
Other current liabilities
Deferred tax liability	1,930,495
Total Current Liabilities	59,780,625
Notes payable - noncurrent	149,637
Other noncurrent liabilities
Derivative liability - convertible notes	2,545,810
Derivative liability - warrants
Warrants to be issued
Total Liabilities	62,476,072
Redeemable non-controlling interest
Stockholders' Equity :
Common stock, $.001 par value; authorized 750,000,000 and 750,000,000 shares at January 31, 2019 and July 31, 2018, respectively; 60,362,164 and 22,430,121 issued and outstanding at January 31, 2019 and July 31, 2018, respectively	60,362
Common stock payable	201,294
Additional paid-in capital	384,414,252
Accumulated deficit	(403,460,965)
Accumulated other comprehensive income	800,446
Non-controlling interest	25,757,598
Total Stockholders' Deficiency	10,588,562
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	73,064,634
As Previously Reported [Member] | Olaregen Series A Preferred Stock [Member]
Stockholders' Equity :
Convertible Preferred Stock	1,000,000
As Previously Reported [Member] | Series I Convertible Preferred Stock
Stockholders' Equity :
Convertible Preferred Stock
As Previously Reported [Member] | Regentys Series A Redeemable Convertible Preferred Stock [Member]
Stockholders' Equity :
Convertible Preferred Stock	1,815,575
As Previously Reported [Member] | Series H Convertible Preferred Stock
Stockholders' Equity :
Convertible Preferred Stock